ArticleEuropean journal of clinical pharmacology2025

Evaluation of surrogate endpoints in phase III randomized control trials of advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.

Ke Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.